INVO Bioscience, Inc. (NASDAQ: INVO) , a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, announced today that Steve Shum , CEO of INVO Bioscience, will present at Tribe Public’s Webinar
April 12, 2021
· 3 min read